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Abstract 
Background: The severe acute respiratory syndrome virus SARS-CoV-2, a close relative of the SARS-CoV virus, is the 
cause of the recent COVID-19 pandemic affecting, to date, over 14 million individuals across the globe and demon-
strating relatively high rates of infection and mortality. A third virus, the H5N1, responsible for avian influenza, has 
caused infection with some clinical similarities to those in COVID-19 infections. Cytokines, small proteins that modu-
late immune responses, have been directly implicated in some of the severe responses seen in COVID-19 patients, e.g. 
cytokine storms. Understanding the immune processes related to COVID-19, and other similar infections, could help 
identify diagnostic markers and therapeutic targets.
Methods: Here we examine data of cytokine, immune cell types, and disease associations captured from biomedical 
literature associated with COVID-19, Coronavirus in general, SARS, and H5N1 influenza, with the objective of identify-
ing potentially useful relationships and areas for future research.
Results: Cytokine and cell-type associations captured from Medical Subject Heading (MeSH) terms linked to thou-
sands of PubMed records, has identified differing patterns of associations between the four corpuses of publications 
(COVID-19, Coronavirus, SARS, or H5N1 influenza). Clustering of cytokine-disease co-occurrences in the context of 
Coronavirus has identified compelling clusters of co-morbidities and symptoms, some of which already known to be 
linked to COVID-19. Finally, network analysis identified sub-networks of cytokines and immune cell types associated 
with different manifestations, co-morbidities and symptoms of Coronavirus, SARS, and H5N1.
Conclusion: Systematic review of research in medicine is essential to facilitate evidence-based choices about health 
interventions. In a fast moving pandemic the approach taken here will identify trends and enable rapid comparison to 
the literature of related diseases.
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Background
The recent respiratory disease pandemic (COVID-19) 
[1], caused by the severe acute respiratory syndrome 
(SARS) Coronavirus 2 (SARS-CoV-2), has both high 
rates of infection as well as high mortality rates [2, 3]. In 
many inflammatory diseases, signaling proteins termed 
cytokines play a critical role in disease pathology. These 
proteins are secreted mainly from hematopoietic cells 
including lymphocytes and macrophages, and along with 
such cells, play a central role in many diseases as well 
as in health [4–7]. In the case of COVID-19, and other 
viral diseases, they can significantly affect the course 
and outcome for the patient. This may manifest itself as 
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in many patients as highly elevated levels of these pro-
teins during acute disease. While first linked to the 1918 
influenza pandemic [8] the cytokine storm was exten-
sively documented in the avian H5N1 influenza virus 
infection [9]. H5N1 influenza virus causes acute lung 
injury as also observed in COVID-19. Acute respiratory 
distress syndrome (ARDS) is the principal cause of res-
piratory failure associated with severe influenza as it is 
with COVID-19 and other members of the Coronavirus 
family. In severe influenza infections the extent of lung 
injury is due to dysregulated inflammatory responses. 
Hence, to compare and contrast immune-related trends 
in H5N1 influenza and Coronavirus infections could ena-
ble clinical research to more effectively consider treat-
ment options.
SARS-CoV-2 is closely related to SARS-CoV, the virus 
responsible for the 2003 SARS pandemic. Since COVID-
19 is an emerging pandemic, there is currently less data 
available on the involvement of the immune system. 
However, the resource available for Coronaviruses more 
generally, SARS more specifically, as well as H5N1 influ-
enza, makes it possible to gain insight into the pathology 
associated with SARS-CoV-2, in respect of pro-inflam-
matory events and lung damage.
One rich, readily available source of immune- and 
disease-related knowledge is the corpus of published 
scientific research. Within research publications, a copi-
ous amount of disease-related trends are captured; these 
can be freely extracted from PubMed records [10]. We 
have previously developed a framework for extracting 
disease-immune relationships from PubMed records by 
relying on the linking of such records to concepts from 
Medical Subject Headings (MeSH) [11]. MeSH is the 
National Library of Medicine’s controlled vocabulary 
thesaurus, consisting of terms (naming and descrip-
tors) within a hierarchical structure; they are used 
for indexing MEDLINE PubMed publications. MeSH 
descriptors associated with each MEDLINE citation are 
manually assigned and provide a straightforward, and 
useful, knowledge resource. Numerous works using con-
cept co-occurrences in biomedical texts or in associated 
MeSH terms have shown the utility of MeSH in captur-
ing biomedical knowledge [12–18]. Our own assessment 
of the ability of MeSH descriptors associated within the 
same PubMed record to represent a true (meaningful and 
feasible) relationship between the terms has shown that 
co-occurrence of MeSH descriptors linked to any given 
PubMed record are a good source for mining dependen-
cies between different types of biomedical entities [11].
The work presented here examines immune-related 
molecular and cellular patterns in the context of COVID-
19, Coronaviruses, SARS, and in H5N1 influenza. By 
identifying links between these conditions and different 
immune system players, novel research can be better tar-
geted at areas of greater impact.
Methods
Extracting PubMed record‑associated MeSH descriptors
A complete description of the approach taken by this 
study can be found in [11]. Briefly, a list of cytokine MeSH 
descriptors (such as “interferon gamma,” “transforming 
growth factor beta,” and “chemokine CCL3”) was manu-
ally compiled by a domain expert, who browsed MeSH’s 
sub-trees and selected those descriptors that were 
deemed relevant to this work. Similarly, a list of immune-
related cell type MeSH descriptors (such as “lympho-
cytes,” “Th1 cells,” and “basophils”) was also compiled. A 
comprehensive list of disease names and synonyms was 
extracted from the Human Disease Ontology.
For each PubMed record (see below) the list of asso-
ciated MeSH descriptors was recorded. The lists of 
cytokine names, cell types, and diseases (described 
above) were then searched for exact matches within the 
MeSH descriptors associated with each PubMed record. 
Next, co-occurrences of cytokines, cell, or disease terms 
were searched for in each PubMed record. These associa-
tions and co-occurrences were then used for the analyses 
described below.
This approach to capturing associations between 
disease, cytokines and different cell types had been 
extensively evaluated, as described in [11]. Briefly, 100 
randomly selected PubMed abstracts were manually 
evaluated by a domain expert who examined whether 
the co-occurrences of MeSH descriptors within the same 
PubMed record represent a true (meaningful and feasi-
ble) relationship between the terms. For each abstract, 
each pair of MeSH descriptors (disease-cell, disease-
cytokine, or cell-cytokine) was evaluated to determine 
whether it represented a true relationship, an indirect 
relationship, or an incorrect/no relationship. Our evalu-
ation found that over 70% of co-occurrences of different 
types of terms (disease, cell type, or cytokine) were found 
to represent true direct or indirect dependencies.
PubMed data
The PubMed database was searched on April 6th, 2020 
for publications tagged with either the ‘Severe Acute 
Respiratory Syndrome’ MeSH term, the ‘influenza a 
virus, h5n1 subtype’ MeSH term, or with the ‘Coronavi-
rus’ MeSH term (excluding those with the SARS Mesh 
term). These searches formed the SARS corpus with a 
total of 4493 records, the H5N1 corpus with a total of 
5975 records, and the Coronavirus corpus with a total of 
9810 records, respectively (Fig. 1). A further search using 
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the ‘COVID-19’ search term was conducted on July 15th 
2020 and resulted in a total of 6029 records.
Clustering and correlation analysis
In order to examine disease similarities based on cytokine 
or cell-type co-occurrences in the context of Coronavi-
rus or SARS, we set out to cluster these patterns of co-
occurrences in the literature. To do so, a quantitative 
cytokine-disease or cell-disease matrix was generated by 
obtaining, for each disease and cytokine/cell in the data, 
a count of the number of records mapped to that disease 
and that cytokine/cell.
Using these matrices as input, hierarchical cluster-
ing was performed using (1-correlation) as the distance 
measure.
Network analysis
Network analysis was carried out with the Cytoscape 
software. One network was created using the information 
extracted from the Coronavirus (but not SARS) corpus; a 
second network was created using data extract from the 
SARS corpus; and a third was created for H5N1. A fourth 
network was generated using data extracted from the 
COVID-19 corpus. Sub-networks were created by select-
ing nodes (primarily disease nodes) of interest and then 
selecting first-degree neighbors. Node and edge attrib-
utes such as, node type, node counts (of occurrences) and 
edge counts (of co-occurrences) were used for colouring, 
sizing, and layout of the networks.
Results
Using a previously published approach [11] associations 
between cytokines, immune cell types, and diseases were 
captured from PubMed records related to COVID-19, 
Coronavirus (in general), SARS and H5N1 influenza. Dif-
fering patterns of associations were identified in a cor-
pus of over 9000 Coronavirus (excluding SARS) related 
publications and compared to those obtained in a corpus 
of over 4000 SARS related publications, and a corpus of 
nearly 6000 H5N1 related publications.
Different cytokines and cell types are associated 
with Coronavirus, SARS and H5N1 influenza
In a comparison of the number of associations of 
cytokines and immune cells with publications between 
the four corpuses, some interesting differences were 
identified (Fig.  2 and Additional file  1). For exam-
ple, Coronavirus is more highly associated with Inter-
feron-gamma than SARS, H5N1 or COVID-19; while 
Interferon-beta is less associated with SARS-related 
publications than Coronavirus- or H5N1-related publica-
tions (Fig. 2a). On the other hand, SARS -related publica-
tions have a higher percentage of those linked to CXCL10 
(interferon-γ inducible protein 10) and Interleukin (IL)-8 
(Fig. 2a). COVID-19 related publications show the high-
est association with IL-6; this may be the result of a focus 
of current research on cytokine storms in COVID-19 
infections. Other differences between the four corpuses 
are found for different immune cells (Fig. 2b).
Immune‑related correlations between diseases associated 
with Coronavirus
Clustering of cytokine-disease co-occurrences in the 
literature has potentially identified novel relationships 
between different diseases that are somehow related to 
Coronavirus.
For example, based on these patterns of cytokine asso-
ciations, the common cold, asthma, and status asthmati-
cus (a severe form of repetitive asthma attacks) were 
clustered together (Fig.  3). A second cluster included 
hypertension, nephritis, chorioretinitis and uvetis, while 
a third interesting cluster included diabetes, hepatitis 
C and B, panuveitis, pneumonia and pseudorabies. It 
should be noted however that there was a relatively small 
number of cytokine-disease co-occurrences in this cor-
pus (when compared for example, to analysis of the entire 
PubMed database as in [11]).
Immune interactions in comorbidities of Coronavirus, SARS 
and H5N1 influenza
Network analysis of the interactions between the differ-
ent entities captured from PubMed records has identi-
fied some interesting and differing sub-networks and 
connections. For example, in the network generated 
from COVID-19 related associations, interesting links 
were found between hypertension and IL-6, as well as 
around lymphopenia (Fig.  4).  In Coronavirus-related 
associations (Fig. 5) different links between cytokines and 
immune cells and comorbidities or symptoms associated 
with Coronavirus can be seen. Where asthma and the 
common cold are directly linked to Interferon-gamma 
(IFNg), IL-8, IL-2 and IL-5, diarrhea is linked to IL-18. 
Fig. 1 Extraction of PubMed record-associated MeSH descriptors. The lower Venn diagrams represents the occurrences of the different types of 
MeSH descriptors (disease, cell, or cytokine), with overlapping areas representing the co-occurrences between the different term types. * PubMed 
was searched for publications linked to the ‘Coronavirus’ MeSH term but not to the SARS MeSH term. § Updated search of PubMed for Covid-19 
related records conducted July 15th 2020
(See figure on next page.)
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Differences in the types of cells included in each sub-
network can also be seen. Similarly, in the SARS-related 
network, we identify differing sub-networks each around 
a different SARS-related comorbidity (Fig. 6); as we did in 
the H5N1-related network (Fig. 7).   
Discussion
In this work, we examined possible links of interest 
between cytokines, immune system cells and diseases 
in the context of Coronavirus and related infections. By 
mining information captured within biomedical publi-
cations, in the form of MeSH descriptors, and their co-
occurrences, we identified associations that may warrant 
further investigations.
As the literature on SARS-COV-2 develops our 
approach can be reapplied to identify the strongest, 
direct links.
In examining the associations between cell types and 
cytokines, in PubMed records linked to COVID-19, 
Coronavirus (but not SARS), and those linked to SARS, 
we found some differences that may point to aetiologi-
cal differences between SARS-CoV and Coronaviruses 
more generally. Coronavirus-related publications had 
a significantly higher percentage of associations with 
Interferon-gamma, Interferon-beta, T-lymphocytes, and 
macrophages (Fig.  2). On the other hand, SARS-related 
publications had higher associations with C-X-C motif 
chemokine 10 (CXCL10), IL8, and TH2 cells; however, 



















Fig. 2 Associations (% of records in respective corpuses) between different entities (MeSh terms) and the four corpuses of PubMed records (those 
related to COVID-19, those related to SARS, those related to Coronavirus but excluding SARS, and those related to H5N1). a Different cytokines and 
chemokines in the four corpuses. b Different cell types in the four corpuses. Only cytokines or cell types with at least one association are included in 
the plots
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associations found in the Coronavirus-related corpus. 
COVID-19 related publications were highly associ-
ated with IL-6, reflective of the empirical finding of IL-6 
elevation in this disease that in turn relates to cytokine 
release syndrome mooted as a mechanism underlying 
more severe cases of the disease [19–22]. Interestingly, 
COVID-19 publications also showed the highest associa-
tion with the specific hematopoietic cell type, neutrophils 
(activated by and responsive to numerous cytokines). 
When comparing these cytokine and cell occurrences 
to those in H5N1-related publications, some patterns 
are similar to those observed in the Coronavirus-related 
publications; specifically, similar rates of occurrences 
were observed for IFNb, TNFa, IL-18, and Granulocyte-
Macrophage Colony Stimulating Factor (GMCSF), in all 
cases these were higher than in the SARS-related publica-
tions. On the other hand H5N1-related publications had 
similar rates of association for monocytes, CD8-positive, 
and CD4-positive T-lymphocytes to those in SARS, in all 
cases, lower than those in Coronavirus-related publica-
tions but higher than in COVID-19 related publications.
While we cannot rule out that these differences 
between the four corpuses are partially due to noise, or 
random variance, it is likely that differences in research 
focus reflect an underlying cause, and this may reflect 
biological or clinical differences. The clearest picture of 
the key features of COVID-19 disease becomes apparent 
by a consideration of all relevant publications and com-
parison to related diseases. Here we have shown this is 
applicable immediately.
Hierarchical clustering of diseases linked to Coronavi-
rus-related publications has also identified some interest-
ing groupings of diseases and symptoms associated with 
Coronavirus infections. For example, the common cold, 
asthma, and status asthmaticus, are all highly correlated 
based on their pattern of associations with cytokines 
within the Coronavirus-related corpus (Fig. 3). In a sec-
ond example, hypertension, nephritis, chorioretinitis and 
uveitis are all clustered together; and in a third example, 
diabetes, hepatitis C and B, panuveitis, pseudorabies 
all cluster with pneumonia. These clusters may suggest 
Fig. 3 Hierarchical clustering of diseases linked to Coronavirus-related publications, based on their patterns of associations with different cytokines
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similar underlying immunological mechanisms in the 
context of coronaviruses.
In our third analysis, networks illustrating the con-
nections between cytokines, immune cell types and 
different diseases, captured from the four publication 
corpuses, were generated. Sub-networks, each stem-
ming from a selected disease, illustrate some differ-
ences between COVID-19 -, Coronavirus-, SARS-, and 
H5N1-related comorbidities and complications. For 
example, in Coronavirus-related publications, diarrhea, 
one of the reported symptoms of COVID-19, is associ-
ated with IL-18, monocytes, T-lymphocytes, dendritic 
cells and erythrocytes. On the other hand, asthma, a risk 
factor for adverse outcomes in COVID-19, is linked to 
IL-8, IL-5, IL-2, IFNg, eosinophils, and neutrophils. In 
the COVID-19 related network, though based on a lim-
ited number of associations, hypertension is highlighted 
(Fig.  4b); this is now known to be a comorbidity asso-
ciated with increased risk of infection and worse out-
comes of COVID-19 [23, 24], validating our approach. 
This analysis has highlighted some potential targets for 
therapy. For example, IL-5 is a key growth factor for and 
activator of eosinophils (both picked up by our research). 
Eosinophils can be recruited to the lungs, where they 
have a poorly understood role in health and disease [25]. 
It has also been reported eosinophil count is a potential 
marker for COVID-19 patient improvement [26, 27]. 
The role of eosinophils and IL-5 in this disease certainly 
requires further investigation. Treatments for asthma 
that modulate eosinophil action are available; Reslizumab 
and Mepolizumab are anti-IL-5 antibody therapies that 
may have potential in treatment of viral respiratory dis-
ease, if eosinophils are activated [28, 29]. It is speculative 
to comment on the role of eosinophils in COVID-19 dis-
ease; however in overall consideration of a fast develop-
ing literature in a pandemic many possible clinical trial 
options could be considered. As the literature evolves 
we suggest the methodologies described here can play a 
progressive part in rational development of strategies for 
optimal treatment in an informed environment.
a b
c
Fig. 4 Network analysis of associations captured from MeSH terms in COVID-19-related PubMed records. a The whole network. b Sub-network of 
first-degree neighbors of the disease node ‘hypertension’. c Sub-network of first-degree neighbors of the disease node ‘lymphopenia’. Pink nodes 
represent cytokines, blue nodes represent diseases, and orange nodes represent cell types. The width of edges between nodes corresponds to the 
number of associations (co-occurrences) between the two entities; the size of the nodes corresponds to the count of that entity within the mined 
corpus
Page 8 of 11Geifman and Whetton  J Transl Med          (2020) 18:297 
Our approach to capturing immune-related associa-
tions from MeSH descriptors is not without limitations. 
We first assume that co-occurrences of MeSH descriptors 
within a PubMed record represent a true relationship or 
dependency; further, some of the associations and co-
occurrences were low (i.e. present in only few records). 
However, our previous investigation into the extent to 
which MeSH term co-occurrence captures real associa-
tion has found that at least 70% of co-occurrences of dif-
ferent types of entities (disease, cell type, or cytokine) 
represent true direct or indirect dependencies, but it is 
likely to be higher than that [11]. Additionally, patterns 
of MeSH co-occurrence have shown to capture known 
medical associations, as well as identify potentially novel 
ones, thus providing further confidence in the approach. 
A second limitation is a lack of directionality and type for 
the associations captured by approach; nevertheless, we 
show that these mere co-occurrences may still hold valu-
able information. Finally, at the time of writing, too few 
publications directly related to COVID-19 that reported 
immune involvement and mechanisms are available 
in PubMed. While many COVID-19 publications are 
a c
b d
Fig. 5 Network analysis of associations captured from MeSH terms in Coronavirus-related PubMed records. a The whole network. b Sub-network 
of first-degree neighbors of the disease node ‘diarrhea’. c Sub-network of first-degree neighbors of the disease node ‘common cold’. d Sub-network 
of first-degree neighbors of the disease node ‘asthma’. Pink nodes represent cytokines, blue nodes represent diseases, and orange nodes represent 
cell types. The width of edges between nodes corresponds to the number of associations (co-occurrences) between the two entities; the size of the 
nodes corresponds to the count of that entity within the mined corpus
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available in preprint repositories these could not be 
mined by our approach which relies on the curated asso-
ciation with MeSH. The consensus view on scientific 
method leads us to argue our method is better applied 
to peer reviewed publications. While our approach did 
find some associations in our mined COVID-19 cor-
pus, our data mining in Coronavirus- and other related 
lung-damaging diseases as a proxy for COVID-19 pro-
duced valid comparators in terms of drug targeting and 
an overview of molecular cellular pathology. We recently 
performed an analysis of protein biomarkers in COVID-
19 [30]; this labour-intensive approach produced similar 
data to the methodology we describe here. Thus, we have 
a c
b d
Fig. 6 Network analysis of associations captured from MeSH terms in SARS-related PubMed records. a The whole network. b Sub-network of 
first-degree neighbors of the disease node ‘thrombocytopenia’. c Sub-network of first-degree neighbors of the disease node ‘pneumonia’. d 
Sub-network of first-degree neighbors of the disease node ‘lymphopenia’. Pink nodes represent cytokines, blue nodes represent diseases, and 
orange nodes represent cell types. The width of edges between nodes corresponds to the number of associations (co-occurrences) between the 
two entities; the size of the nodes corresponds to the count of that entity within the mined corpus
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created a paradigm for such research which is easy to use 
and apply, and demonstrated its utility.
Conclusion
Herein, we have identified possible links between 
immune-related patterns, related co-morbidities, com-
plications and symptoms in the context of Coronavi-
rus and related infections. These associations may have 
direct implications for COVID-19 and can help focus 
on potentially useful avenues of future research to 
understanding of the immune mechanisms underlying 
COVID-19 and related complications.
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a c
b d
Fig. 7 Network analysis of associations captured from MeSH terms in H5N1-related PubMed records. a The whole network. b Sub-network of 
first-degree neighbors of the disease node ‘pulmonary edema’. c Sub-network of first-degree neighbors of the disease node ‘lymphopenia’. d 
Sub-network of first-degree neighbors of the disease node ‘pneumonia’. Pink nodes represent cytokines, blue nodes represent diseases, and orange 
nodes represent cell types. The width of edges between nodes corresponds to the number of associations (co-occurrences) between the two 
entities; the size of the nodes corresponds to the count of that entity within the mined corpus
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